Evaluation of congenital hypothyroidism in fars province, iran

Zohreh Karamizadeh1, Hedyeh Saneifard, Golmhossein Amirhakimi

  • 1Division of endocrinology, Department of pediatrics, Shiraz University of Medical Sciences, Shiraz, Iran.

Insights

Evaluating Iran

Area of Science:

  • Neonatal screening
  • Endocrinology
  • Pediatrics

Background:

  • Iran's national healthcare includes thyroid-stimulating hormone (TSH) screening for primary congenital hypothyroidism (CH) since 2005.
  • This study critically evaluates the CH screening program's effectiveness in Fars province.

Purpose of the Study:

  • To assess the performance of the TSH-based neonatal screening program for CH in Fars province, Iran.
  • To determine the prevalence and etiological factors of CH in the region.

Main Methods:

  • Serum TSH levels were measured in 63,031 newborns (3-5 days old) via heel prick.
  • Newborns with TSH ≥5mIU/L were recalled for confirmatory venous blood tests (TSH and T4).

Main Results:

  • A prevalence of 1:1465 was identified, with 43 confirmed CH cases.
  • Common findings included prolonged jaundice (73%) and fontanel abnormalities (56-55%).
  • Thyroid scintigraphy revealed eutopia (67.4%) as the most common presentation, suggesting dyshormonogenesis may be more prevalent than dysgenesis.

Conclusions:

  • The TSH cutoff of ≥5mIU/L leads to over-recalling of infants.
  • Dyshormonogenesis might be a more frequent cause of CH in Iran than previously reported.
  • Programmatic adjustments may be needed to optimize recall rates and diagnostic accuracy.
Abstract

Related Concept Videos

Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Goiter01:27

Goiter

Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...